Calendar Immunome, Inc.

Equities

IMNM

US45257U1088

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 14:08:49 2025-06-18 EDT			5-day change	1st Jan Change
8.920 ^USD	-0.34%		-6.06%	-16.05%

06-05	Immunome Reports Inducement Grants Under Nasdaq Listing Rule	RE
05-23	Sector Update: Health Care Stocks Softer Friday Afternoon	MT

Chart calendar Immunome, Inc.

2d302802fd47247c770d7600.l8c4Tag0yz6jRXP60cXG-olqdtioXl1GysIlAnr8C0Q.-Z5PCssFuETHDwelmr33tPwTLqnYOxQhnY9ESiKMQTTEjwA3_xmtWpBxAA~8602f072145708380e46677dae01e2b1

Upcoming events on Immunome, Inc.

2025-08-12	Q2 2025 Earnings Release (Projected)
2025-11-16	Q3 2025 Earnings Release (Projected)
2026-03-18	Q4 2025 Earnings Release (Projected)

Past events on Immunome, Inc.

2025-06-10 14:00	Goldman Sachs Global Healthcare Conference
2025-06-10 11:30	Annual General Meeting
2025-05-27 09:30	TD Cowen Oncology Innovation Summit
2025-05-12 16:05	Q1 2025 Earnings Release
2025-04-10 12:45	Needham Healthcare Conference - Fireside Chat
2025-03-19 16:05	Q4 2024 Earnings Release
2025-03-10 13:40	Leerink Partners Global Healthcare Conference
2025-03-04 13:10	TD Cowen Healthcare Conference
2025-01-15 12:45	JP Morgan Healthcare Conference
2024-12-03 16:30	Piper Sandler Healthcare Conference
2024-11-13 16:05	Q3 2024 Earnings Release
2024-11-13 10:30	Guggenheim Securities Healthcare Innovation Conference
2024-09-13	European Society of Medical Oncology Congress - Abstract No: 1766P
2024-09-04 17:35	Morgan Stanley Healthcare Conference - Fireside Chat
2024-08-12 16:01	Q2 2024 Earnings Release
2024-06-12 11:30	Annual General Meeting
2024-05-15 13:40	BofA Securities Health Care Conference
2024-05-14 08:00	Q1 2024 Earnings Release
2024-04-09 16:30	American Association for Cancer Research Meeting - Abstract No: 6026
2024-03-28 16:02	Q4 2023 Earnings Release

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026	2027
Net sales Million USD	Released Forecast Spread	0,00 0,00 -	14,0 12,3 14.3%	9,04 9,41 -3.88%	4,22	15,5	62,2
EBITDA	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00	0,00	0,00
EBIT Million USD	Released Forecast Spread	-36,9 -38,0 2.92%	-28,7 -29,3 1.96%	-306 -267 -14.35%	-189	-211	-209
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-36,9 -38,0 2.92%	-107 -30,7 -247.93%	-293 -254 -15.18%	-176	-199	-187
Net income Million USD	Released Forecast Spread	-37,5 -38,0 1.28%	-107 -27,6 -286.53%	-293 -255 -14.7%	-184	-214	-212
EPS USD	Released Forecast Spread	-3,09 -3,08 -0.49%	-5,38 -0,97 -454.64%	-5,00 -4,38 -14.08%	-2,21	-2,41	-2,20
Announcement Date		16/03/23	28/03/24	19/03/25	-

Quarterly results

Fiscal Period	March	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales Million USD	Released Forecast Spread		3,83 2,07 85.13%	1,03 2,80 -63.25%	2,36 1,87 26.64%	2,91 2,23 30.27%	2,74 3,16 -13.24%	2,93 0,46 540.07%	1,03	0,63	-0,36	0,00	0,00	2,00	3,70
EBIT Million USD	Released Forecast Spread		-13,9 -10,4 -33.11%	-132 -27,0 -389.39%	-40,0 -26,0 -53.7%	-50,5 -37,2 -35.79%	-83,0 -44,6 -86.19%	-44,6 -51,4 13.22%	-45,9	-47,4	-51,1	-51,9	-53,9	-53,6	-55,3
Earnings before Tax (EBT) Million USD	Released Forecast Spread		-92,6 -12,6 -638.03%	-129 -26,3 -392.78%	-36,1 -24,1 -49.69%	-47,1 -34,8 -35.42%	-80,2 -41,7 -92.5%	-41,6 -48,4 13.94%	-42,6	-44,1	-47,8	-49,5	-51,4	-50,4	-49,5
Net income Million USD	Released Forecast Spread	-4,35	-92,6 -12,0 -674.04%	-129 -39,2 -229.98%	-36,1 -21,7 -66.39%	-47,1 -34,4 -37.04%	-80,2 -42,8 -87.67%	-41,6 -50,7 17.92%	-44,0	-46,8	-51,7	-50,4	-52,8	-52,8	-54,0
EPS USD	Released Forecast Spread	-0,36	-4,22 -0,28 -1389.43%	-2,51 -0,69 -261.67%	-0,60 -0,39 -52.57%	-0,78 -0,57 -37.19%	-1,11 -0,64 -73.46%	-0,52 -0,66 20.72%	-0,53	-0,56	-0,60	-0,60	-0,62	-0,59	-0,59
Announcement Date		09/11/23	28/03/24	14/05/24	12/08/24	13/11/24	19/03/25	12/05/25	-	-	-	-	-	-	-

Upcoming sector events for Immunome, Inc.

2025-07-02	KALVISTA PHARMACEUTICALS, INC.: Q4 2025 Earnings Release (Projected)
2025-07-09	NURIX THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
2025-07-22	VIKING THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
2025-07-23	BIOCON LIMITED: Q1 2026 Earnings Release (Projected)
2025-07-29	CASSAVA SCIENCES, INC.: Q2 2025 Earnings Release (Projected)
2025-07-29	XENCOR, INC.: Q2 2025 Earnings Release (Projected)
2025-07-30	DYNE THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
2025-07-30	KURA ONCOLOGY, INC.: Q2 2025 Earnings Release (Projected)
2025-07-30	SANA BIOTECHNOLOGY, INC.: Q2 2025 Earnings Release (Projected)
2025-07-30	KEROS THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)

More events

Past sector events for Immunome, Inc.

2025-06-12	SANBIO COMPANY LIMITED: Q1 2025 Earnings Release
2025-06-09 02:46	LUMOSA THERAPEUTICS CO., LTD.: May 2025 Sales and Revenue Release
2025-06-05 04:21	PHARMAESSENTIA CORPORATION: May 2025 Sales and Revenue Release
2025-05-15 08:00	TAYSHA GENE THERAPIES, INC.: Q1 2025 Earnings Release
2025-05-14	LIGACHEM BIOSCIENCES INC.: Q1 2025 Earnings Release
2025-05-14	PEPTRON, INC.: Q1 2025 Earnings Release
2025-05-14	OLIX PHARMACEUTICALS, INC: Q1 2025 Earnings Release
2025-05-14 16:05	ENLIVEN THERAPEUTICS, INC.: Q1 2025 Earnings Release
2025-05-14 07:00	SCHOLAR ROCK HOLDING CORPORATION: Q1 2025 Earnings Release
2025-05-13 21:00	BELITE BIO, INC: Q1 2025 Earnings Release